Navigation Links
China Pharma Holdings, Inc. Donates Medicine for Sichuan Earthquake Relief
Date:5/16/2008

NEW YORK and HAIKOU, China, May 16 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and brand bio-pharmaceutical products in China, announced today that it donated 2 million RMB (approximately US$285,714) worth of its products including antibiotics, anti- virus and anti-cold medicines to help disaster relief in China after a strong earthquake hit the southwestern province of Sichuan.

On May 12, a 7.9-magnitude quake struck in Wen Chuan Sichuan province China and toppled schools, apartment buildings and factories. Thousands of people were killed or trapped in mounds of concrete, steel and earth in the country's worst quake in three decades. China Pharma quickly reacted to the tragedy and made a donation of medicines to the earthquake-hit areas starving for help. Meanwhile, every employee of China Pharma is actively making donations for the survivors of this devastating earthquake in Sichuan.

"I am extremely shocked and saddened by the extent of the destruction caused by this earthquake in Sichuan Province. Our company and our employees feel a profound sympathy for the people suffering from this terrible tragedy at this time, and we are offering our support to these people and their families and sincerely hope that they could rebuild their homes in the near future," Ms. Zhilin Li, President and CEO of China Pharma Holdings, Inc. said.

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. For more information a
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Biologic Products Reports First Quarter 2008 Results
2. China Biologic Products Announces First Quarter 2008 Results Conference Call
3. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
4. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
5. China Sky One Medical, Inc. Changes Management Team
6. China Sky One Medical, Inc. Announces Record First Quarter 2008 Results
7. China Medicine Announces Solid First Quarter 2008 Results
8. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
9. China-Biotics, Inc. Completes Foundation for Its New Plant
10. Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
11. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 S&P Capital IQ (MHFI) ... Report coverage on MabVax Therapeutics Holdings Inc . ... clinical stage biotechnology company focused on the development of ... in the treatment of cancer. MabVax has discovered a ... protective immune responses generated by patients who have been ...
(Date:2/26/2015)... Feb. 26, 2015 On behalf of biotech ... companies, Wilentz, Goldman & Spitzer, P.A. (Wilentz) ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... denying motions for judgment notwithstanding the verdict, a new ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
(Date:2/26/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... that develops and commercializes proprietary technologies and products for ... results for the fiscal first quarter ended December  31, ... Canadian dollars (CAD), unless otherwise stated. ... business from our existing customers and add to our ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 323andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... 16 IR BioSciences,Holdings, Inc. (OTC Bulletin Board: ... and CEO Michael K. Wilhelm. The purpose of ... shareholders on its subsidiary,ImmuneRegen BioSciences, past year of ... ImmuneRegen today has also filed a Form,8-K containing ...
... in the Fourth ... Quarter, ... from a 12-week, Phase 3 clinical,trial of FENTORA(R) (fentanyl buccal tablet) [C-II] ... pain,conditions. The study achieved statistical significance on the primary,endpoint. Results across the ...
... CITY, Aug. 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(TSX: ... on,endocrine therapy and oncology, today announced the filling ... the appointment of Paul Blake,M.D., as Senior Vice ... of Dr. Blake is timely and critical as ...
Cached Biology Technology:ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 2ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 3ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 4Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 2Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 3Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 4Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 5AEterna Zentaris completes management team with the appointment of Chief Medical Officer 2AEterna Zentaris completes management team with the appointment of Chief Medical Officer 3
(Date:2/25/2015)... , Feb. 25, 2015  ABC Financial ... billing in the Health and Fitness Industry, today ... as to MYiCLUBonline.  The latest upgrade includes advances ... inclusion of cardless check-in via Identity One fingerprint ... first time through interactive displays at the International ...
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle ... Annual estimates and forecasts are provided for the period 2013 ... these markets. Market data and analytics are derived from primary ...
(Date:2/24/2015)... YORK , Feb. 24, 2015 This report analyzes ... by the following Segments: Face Biometrics, and Voice Biometrics. The report ... , Japan , Europe , ... & Africa , and Latin America ... 2013 through 2020. Also, a seven-year historic analysis is provided for ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16
... Angelman syndrome, a neurological disorder that causes mental retardation ... has been developed by biologists at The University of ... a particular fruit fly gene, dube3a, is altered, the ... by humans whose UBE3A gene doesn,t function normally. ...
... MSG, as a flavor enhancer in their food are more likely ... even though they have the same amount of physical activity and ... Chapel Hill School of Public Health study published this month in ... China studied more than 750 Chinese men and women, aged between ...
... a deep-sea bloodhound, Sentry the newest in an ... their own in demanding and rugged environments has ... of a pioneering seafloor laboratory being planned off Washington ... a crucial step in developing an extensive sensor network ...
Cached Biology News:Model for angelman syndrome developed by University of Texas at Austin biologists 2UNC researchers find MSG use linked to obesity 2New robot scouts best locations for components of undersea lab 2New robot scouts best locations for components of undersea lab 3
... Rhesus Serum • Rhesus serum is ... and 5-7 years of age. Available ... Heparin (Na) N-06: K2EDTA ... (Na) N-03: Alsevers N-05: ...
Collected from sexually mature, mixed sex, mixed breed guinea pigs. Pricing: $120/unit for 1 - 10 units...
Active GST Protein...
Marmoset plasma and serum - various quantities available...
Biology Products: